Fluid delivery methods
US-2024408593-A1 · Dec 12, 2024 · US
US2022282317A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2022282317-A1 |
| Application number | US-202217730004-A |
| Country | US |
| Kind code | A1 |
| Filing date | Apr 26, 2022 |
| Priority date | Oct 4, 2017 |
| Publication date | Sep 8, 2022 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Activity-based probes that can be used to selectively identify and characterize enzymes that are involved in different phases of xenobiotic metabolism in a host and its microbiota population(s) are described. The activity-based probes described specifically label only their target active enzymes involved in xenobiotic metabolism and therefore provide a measurement of true protein functional activity rather than transcript or protein abundance. The activity-based probes also provide multimodal profiling of these active enzymes. Methods for preparing the activity based probes and exemplary methods for their use also are disclosed.
Opening claim text (preview).
We claim: 1 . A method comprising: exposing a subject or a sample to a probe for a time sufficient to allow the probe to bind to an enzyme involved in xenobiotic metabolism such that a probe-enzyme conjugate is formed; and analyzing the probe-enzyme conjugate using a fluorescent detection technique, a colorimetric detection technique, a mass spectrometry technique, or a combination thereof; wherein the probe comprises a compound of Formula II wherein ERG, if present, is S(O) 2 OH, or an anionic form thereof; P(O)(OH) 2 , or an anionic form thereof; a halogen; or —OPh-CH 2 —ONO 2 ; EBG has a structure satisfying one or more of Formulas IIA EBG -IIJ EBG wherein Y is CH 3 or CF 3 ; Y′ is O, NO 2 , or —N═NR″, wherein R″ is a dye or other reporting moiety; m is an integer selected from 0 to 5; and R′ is selected from aldehyde, ketone, ester, carboxylic acid, acyl, acyl halide, cyano, sulfonate, nitro, nitroso, quaternary amine, CF 3 , alkyl halide, or combinations thereof; Linker a comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromatic group; each of Linker b and Linker c , if present, independently comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromatic group; R, if present, is a group comprising a carbamate or a carbonate; each Tag, if present, independently comprises a functional group or molecule capable of generating a detectable signal; each p Tag, which is present if a Tag is not present, independently comprises a clickable functional group; and each of n, m, p, and q independently is 0 or 1. 2 . The method of claim 1 , further comprising exposing the probe-enzyme conjugate to a Tag-containing compound to form a probe-enzyme conjugate comprising a Tag moiety. 3 . The method of claim 1 , further comprising exposing the probe to a light source. 4 . The method of claim 1 , further comprising extracting a subject sample from the subject and analyzing the subject sample using a fluorescent detection technique, a colorimetric detection technique, a mass spectrometry technique, or a combination thereof. 5 . The method of claim 1 , wherein Linker a is a linker group having a structure satisfying one or more of Formulas IIA Linkera -IIH Linkera wherein each n′ independently is an integer ranging from 1 to 50; Z is oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic; and Q is carbon, oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic. 6 . The method of claim 1 , wherein at least one of the following applies: (a) Linker b is present and comprises a —(CH 2 ) n′ — group, wherein n′ is an integer ranging from 1 to 50; an amide group; or a combination thereof; and/or (b) Linker c is present and has a structure satisfying Formula IIA Linkerc or Formula IIB Linkerc wherein n′ is an integer ranging from 0 to 50; and Z is oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic. 7 . The method of claim 1 , wherein R is present and has a structure of one of Formulas IIA R -IID R wherein Z and Z′ independently are oxygen or NR′″, wherein R′″ is hydrogen, aliphatic, or aromatic; and n′ is an integer ranging from 0 to 50. 8 . The method of claim 1 , wherein one or more Tags are present and wherein each Tag independently is a fluorophore, a binding partner of an affinity-based binding pair, a quantum dot, or a dye. 9 . The method of claim 1 , wherein the one or more Tags independently are rhodamine, fluorescein, or biotin. 10 . The method of claim 1 , wherein one or more p Tags are present and wherein each p Tag independently is an azide or an alkyne. 11 . The method of claim 1 , wherein the compound has a structure satisfying Formula IIIA 12 . The method of claim 1 , wherein the ERG is present and is iodo; —OPh-CH 2 —ONO 2 ; 13 . The method of claim 1 , wherein Linker a is an ester group, an —O(CH 2 ) n′ NR′″C(O)(CH 2 ) n′ — group, or a —(CH 2 ) n′ — group, wherein each n′ independently is an integer ranging from 1 to 20 and wherein R′″ is hydrogen, aliphatic, or aromatic. 14 . The method of claim 1 , wherein m is 1 and Linker c is an —NR′″C(O)(CH 2 ) n′ — group or an —NR′″C(O)CH 2 [O(CH 2 ) 2 ] n′ OCH 2 — group, wherein each n′ independently is an integer ranging from 1 to 20 and wherein R′″ is hydrogen, aliphatic, or aromatic. 15 . The method of claim 1 , wherein m is 1 and each Tag, if present, independently is a fluorophore, a binding partner of an affinity-based binding pair, a quantum dot, or a dye; or if a p Tag group is present, then each p Tag independently is an alkyne or an azide. 16 . The method of claim 1 , wherein the probe is selected from: 17 . The method of claim 1 , wherein in Formula (II): ERG is EBG has a structure selected from wherein Y′ is O; m′ is an integer selected from 0 to 5; and each occurrence of R′ is independently selected from aldehyde, ketone, ester, carboxylic acid, acyl, acyl halide, cyano, sulfonate, nitro, nitroso, quaternary amine, CF 3 , alkyl halide, or combinations thereof; Linker a comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromatic group; each of Linker b and Linker c , if present, independently comprises an aliphatic group, a heteroaliphatic group, an aromatic group, an aliphatic-aromatic group, a heteroaliphatic-aromatic group, a heteroaromatic group, an aliphatic-heteroaromatic group, or a heteroaliphatic-heteroaromat
to a carbon atom of a non-condensed six-membered aromatic ring · CPC title
Glutathione transferases (2.5.1.18) · CPC title
Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism · CPC title
substituted in position 7 · CPC title
having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.